secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLAUKOS Corp (GKOS)
CIK:        0001192448
Form:       8-K
Filed at:   2026-04-29T23:59:59+00:00
Accession:  0001193125-26-191553
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glaukos Q1 record sales $150.6M (+41% YoY); raises FY2026 guidance to $620-635M
-------------------------------------------------------------------------------

- Record net sales $150.6M (+41% YoY, +39% constant currency).
- U.S. Glaucoma net sales $93.5M (+58% YoY); Glaucoma total $129.3M (+47% YoY).
- GAAP net loss ($0.34)/share; non-GAAP net loss ($0.18)/share; operating loss narrowed YoY.
- FY2026 net sales guidance raised to $620-635M from prior $600-620M.
- Cash $280.5M, no debt; GAAP gross margin ~78%, non-GAAP ~84%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1192448/000119312526191553/0001193125-26-191553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1192448/000119312526191553/gkos-20260429.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-191553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer